La Peer Health Systems Gastroenterologist Named a Vitals Top Ten Doctor
I wish there was a different answer for many patients with true celiac disease (whether they have symptoms or not). For now, a strict gluten-free diet for life is the only treatment option. Below I discuss future treatment options that may become available, but still only considered within research frameworks at this time. Mylea Charvat asks: With celiac will I ever be able to eat regular pastas and breads again? Is there any research into medication to help those diagnosed with celiac disease digest and tolerate gluten? I wish there were better news for the here and now. Unfortunately, as you know, a strict gluten-free diet a for now a is the only treatment option for celiac disease. Regular pastas and breads are definitely hard to give up, especially if you really enjoy them. With that said, many laboratories around the world are evaluating different strategies to offer celiac patients more therapeutic options in the future. One hopeful approach is aglutenase therapya where an enzyme could break down the gluten and render it non-toxic. Other working ideas include: blocking the immune reaction (i.e., auto-antibodies) through an ingestible polymeric resin, adesensitizinga the bodyas immune system response to gluten via serial protein-based injections and developing a celiac vaccine. Looking ahead, it is conceivable that celiac patients will one day be able to eat gluten-containing foods, but definitive alternatives to gluten avoidance are not yet ready for general consumer use. Antonio Ruben Murcia Prieto asks: What aboutAoats for celiac disease?
This is a wonderful honor, and I am deeply grateful to my patients for their positive reviews, said Dr. Elihu. The satisfaction of my patients with their experience with me is important, and I plan to continue my practice with this in mind. Patients in the U.S. trust Vitals as their source for making informed health choices, and rely on Vitals to help them select the best health facility or doctor for them. Vitals provides trusted relationships between patients and doctors through thorough patient ratings and reviews, aiding in the improvement of overall health care. Each doctor who receives the Top Ten Doctors award has maintained consistent top ratings from patients, and Dr. Elihu has been recognized for his expertise in diagnosing and treating digestive orders , with special emphasis on the prevention of colorectal, stomach and esophageal cancers. Selecting a surgeon, physician or other doctor is an important decision process for patients, and can sometimes seem like an unclear path. Vitals provides powerful resources about doctors for patients, helping to simplify the selection process and enable patients to make the right health care choices. My practice is founded on the principle of providing personalized patient care, said Dr. Elihu. Every patient’s condition or situation is unique, and must be diagnosed and treated as such. Maurice Elihu, MD is a board-certified gastroenterologist that specializes in the comprehensive evaluation of digestive disorders with emphasis on prevention of colorectal, esophageal, and stomach cancers. After completion of seven years of extensive postgraduate training in New York, Dr. Elihu returned to Los Angeles to better serve the community where he grew up. He is also an active member of American College of Gastroenterology & Southern California Society of Gastroenterology as well as a Diplomate of the American Board of Internal Medicine and American Board of Gastroenterology. Dr.
American College of Gastroenterology Applauds U.S. Preventive Services Task Force for New Hepatitis C Testing Recommendation
Seperate multiple addresses with Commas. Must enter an email address. You must enter the verification code below to send. Invalid entry: Please type the verification code again. The Wall Street Journal news department was not involved in the creation of this content. PRESS RELEASE June 25, 2013, 1:09 p.m. ET American College of Gastroenterology Applauds U.S. Preventive Services Task Force for New Hepatitis C Testing Recommendation Text BETHESDA, Md., June 25, 2013 /PRNewswire-USNewswire/ — The American College of Gastroenterology (ACG) praises the U.S. Preventive Services Task Force (USPSTF) for updating the hepatitis C virus (HCV) screening recommendations for all adults born between 1945 to 1965, the “boomer” generation. HCV is the most common chronic blood-borne disease in the United States and is a leading cause of complications from chronic liver disease. The USPSTF members concluded that “the benefit of screening for HCV infection in persons in the birth cohort is likely similar to the benefit of screening in persons at higher risk for infection.” A similar screening was recommended by the Centers for Disease Control and Prevention in 2012. Gastroenterologists treat patients with liver disease, and, along with their liver specialist colleagues in hepatology, are on the front line treating patients with chronic viral hepatitis. “The American College of Gastroenterology recognizes the clinical challenges and realities of screening and treating chronic hepatitis C in community settings and is pleased that more undiagnosed patients can start getting the medical care they need upon diagnosis,” said ACG President Ronald J. Vender, MD, FACG. There is significant clinical evidence that, based on age alone, screening among asymptomatic adults can result in better outcomes by earlier treatment. New treatments for hepatitis C are more effective than ever in curing the infection, and may halt progression to cirrhosis, liver failure, liver cancer and death.